New approaches to the design of clinical trials in idiopathic pulmonary fibrosis

Author： Cerri Stefania   Del Giovane Cinzia   Balduzzi Sara   Soncini Francesco   Sdanganelli Antonia   Richeldi Luca  

Publisher： Future Science

ISSN： 2041-6792

Source： Clinical Investigation, Vol.3, Iss.6, 2013-06, pp. : 531-544

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical trials of idiopathic pulmonary fibrosis: choosing the (right) primary end point

By Spagnolo Paolo   Luppi Fabrizio  

Clinical Investigation, Vol. 3, Iss. 12, 2013-12 ,pp. : 1139-1146

Future Science

Access to resources Recommend Favorite

Idiopathic Pulmonary Fibrosis: Recent Trials and Current Drug Therapy

By  

Respiration, Vol. 86, Iss. 5, 2013-11 ,pp. : 353-363

Karger

Access to resources Recommend Favorite

Clinical Correlates of Reduced Physical Activity in Idiopathic Pulmonary Fibrosis

By  

Respiration, Vol. 91, Iss. 6, 2016-06 ,pp. : 497-502

Karger

Access to resources Recommend Favorite

Induced Sputum: A New Tool to Monitor Idiopathic Pulmonary Fibrosis?

By  

Respiration, Vol. 72, Iss. 1, 2005-02 ,pp. : 26-27

Karger

Access to resources Recommend Favorite

Immunoglobulin A in serum: an old acquaintance as a new prognostic biomarker in idiopathic pulmonary fibrosis

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 181, Iss. 2, 2015-08 ,pp. : 357-361

John Wiley & Sons Inc

Access to resources Recommend Favorite